coronary heart disease

The clinical trial with Huntsville Heart Center is expected to be completed by October.

The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.

The risk assessment tool can potentially determine if plaque build-up has narrowed a patient's coronary arteries.

A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.

Yesterday, Redwood City, California-based HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that it landed $240 million in series E funding led by Wellington Management Company and Baillie Gifford & Company.

A relatively large randomized control trial in Australia has shown that a text messaging program can improve not only health behaviors, but actually affect health outcomes.